Literature DB >> 10072717

Expression of cardiac cytokines and inducible form of nitric oxide synthase (NOS2) in Trypanosoma cruzi-infected mice.

H Huang1, J Chan, M Wittner, L A Jelicks, S A Morris, S M Factor, L M Weiss, V L Braunstein, C J Bacchi, N Yarlett, M Chandra, J Shirani, H B Tanowitz.   

Abstract

Expression of Cardiac Cytokines and Inducible Form of Nitric Oxide Synthase (NOS2) in Trypanosoma cruzi-infected Mice. Journal of Molecular and Cellular Cardiology (1999) 31, 75-88. Both cardiac cytokine and inducible nitric oxide synthase (NOS2) expression have been implicated in the cardiac dysfunction associated with myocarditis and cardiomyopathy. Chagas' disease, caused by Trypanosoma cruzi, is an important cause of cardiomyopathy. We examined the effect of T. cruzi (Brazil strain) infection with or without verapamil treatment on the expression of cytokines and NOS2 in the heart. Messenger RNA for NOS2, IL-1beta, and TNF-alpha was induced in the myocardium of infected mice, and Western blot analysis as well as immunohistochemistry demonstrated a significant increase in NOS2 protein. Verapamil treatment reduced the expression of cardiac NOS2 protein and the mRNAs for NOS2, TNF-alpha, and IL-1beta. Infection-associated increases in cardiac L-citrulline were also reduced by verapamil treatment. Verapamil-treated infected mice that survived for 80 days exhibited less inflammation and fibrosis compared to untreated mice. Gated MRI and echocardiography revealed an increased right ventricular inner diameter (RVID) in untreated but not in verapamil-treated infected CD1 mice. This suggests that the infection-associated expression of cytokines and NOS2 in the heart correlate with the severity of myocarditis and the effect of verapamil. The RVID was significantly increased in infected wild-type (WT) compared to infected syngeneic NOS2 knockout (NOS2-/-) mice. Fractional shortening was decreased and myocardial L-citrulline was increased in infected WT mice. These data suggest that NO generated from cardiac NOS2 may participate in the pathogenesis of murine chagasic heart disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10072717     DOI: 10.1006/jmcc.1998.0848

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  53 in total

1.  Trypanosoma cruzi infection: do distinct populations cause intestinal motility alteration?

Authors:  Monica de Melo Medeiros; Tania C Araújo-Jorge; Wanderson S Batista; Tshaca Mahatma Oara Alves da Silva; Andréa Pereira de Souza
Journal:  Parasitol Res       Date:  2010-05-08       Impact factor: 2.289

Review 2.  Chagas heart disease: report on recent developments.

Authors:  Fabiana S Machado; Linda A Jelicks; Louis V Kirchhoff; Jamshid Shirani; Fnu Nagajyothi; Shankar Mukherjee; Randin Nelson; Christina M Coyle; David C Spray; Antonio C Campos de Carvalho; Fangxia Guan; Cibele M Prado; Michael P Lisanti; Louis M Weiss; Susan P Montgomery; Herbert B Tanowitz
Journal:  Cardiol Rev       Date:  2012 Mar-Apr       Impact factor: 2.644

3.  New drugs for neglected infectious diseases: Chagas' disease.

Authors:  Fabiana S Machado; Herbert B Tanowitz; Mauro M Teixeira
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

4.  Trypanosoma cruzi infection results in the reduced expression of caveolin-3 in the heart.

Authors:  Daniel Adesse; Michael P Lisanti; David C Spray; Fabiana S Machado; Maria de Nazareth Meirelles; Herbert B Tanowitz; Luciana Ribeiro Garzoni
Journal:  Cell Cycle       Date:  2010-04-15       Impact factor: 4.534

5.  Crucial role of the central leptin receptor in murine Trypanosoma cruzi (Brazil strain) infection.

Authors:  Fnu Nagajyothi; Dazhi Zhao; Fabiana S Machado; Louis M Weiss; Gary J Schwartz; Mahalia S Desruisseaux; Yang Zhao; Stephen M Factor; Huan Huang; Chris Albanese; Mauro M Teixeira; Philipp E Scherer; Streamson C Chua; Herbert B Tanowitz
Journal:  J Infect Dis       Date:  2010-10-01       Impact factor: 5.226

6.  Cell-specific activation of nuclear factor-kappaB by the parasite Trypanosoma cruzi promotes resistance to intracellular infection.

Authors:  B S Hall; W Tam; R Sen; M E Pereira
Journal:  Mol Biol Cell       Date:  2000-01       Impact factor: 4.138

Review 7.  Current status of cardiac MRI in small animals.

Authors:  J-P Vallée; M K Ivancevic; D Nguyen; D R Morel; M Jaconi
Journal:  MAGMA       Date:  2004-12-16       Impact factor: 2.310

8.  Alterations in glucose homeostasis in a murine model of Chagas disease.

Authors:  Fnu Nagajyothi; Regina Kuliawat; Christine M Kusminski; Fabiana S Machado; Mahalia S Desruisseaux; Dazhi Zhao; Gary J Schwartz; Huan Huang; Chris Albanese; Michael P Lisanti; Rajat Singh; Feng Li; Louis M Weiss; Stephen M Factor; Jeffrey E Pessin; Philipp E Scherer; Herbert B Tanowitz
Journal:  Am J Pathol       Date:  2013-01-12       Impact factor: 4.307

9.  Nitric oxide synthase-2 modulates chemokine production by Trypanosoma cruzi-infected cardiac myocytes.

Authors:  Fabiana S Machado; Janeusa T Souto; Marcos A Rossi; Lisia Esper; Herbert B Tanowitz; Julio Aliberti; João S Silva
Journal:  Microbes Infect       Date:  2008-10-08       Impact factor: 2.700

10.  A magnetic resonance imaging study of intestinal dilation in Trypanosoma cruzi-infected mice deficient in nitric oxide synthase.

Authors:  Lars Ny; Hua Li; Shankar Mukherjee; Katarina Persson; Bo Holmqvist; Dazhi Zhao; Vitaliy Shtutin; Huan Huang; Louis M Weiss; Fabiana S Machado; Stephen M Factor; John Chan; Herbert B Tanowitz; Linda A Jelicks
Journal:  Am J Trop Med Hyg       Date:  2008-11       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.